These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human effects. Jones R NIDA Res Monogr; 1977 Jul; (14):128-78. PubMed ID: 411040 [No Abstract] [Full Text] [Related]
5. Human effects: an overview. Jones RT NIDA Res Monogr; 1980; 31():54-80. PubMed ID: 6775232 [No Abstract] [Full Text] [Related]
6. Interaction of the cannabinoid and opioid systems in the modulation of nociception. Welch SP Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508 [TBL] [Abstract][Full Text] [Related]
7. [Functional organization ant therapeutic potential of the endogenous cannabinoid system]. Churiukanov MV; Churiukanov VV Eksp Klin Farmakol; 2004; 67(2):70-8. PubMed ID: 15188768 [No Abstract] [Full Text] [Related]
8. [Cognitive and psychotic effects after cessation of chronic cannabis use]. van Amsterdam JG; van der Laan JW; Slangen JL Ned Tijdschr Geneeskd; 1998 Mar; 142(10):504-8. PubMed ID: 9623095 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoids:their role in pain and palliation. McCarberg BH J Pain Palliat Care Pharmacother; 2007; 21(3):19-28. PubMed ID: 18032352 [TBL] [Abstract][Full Text] [Related]
10. Cannabis, the mind and society: the hash realities. Murray RM; Morrison PD; Henquet C; Di Forti M Nat Rev Neurosci; 2007 Nov; 8(11):885-95. PubMed ID: 17925811 [TBL] [Abstract][Full Text] [Related]
11. Marijuana. Health and treatment issues. Jones RT Psychiatr Clin North Am; 1984 Dec; 7(4):703-12. PubMed ID: 6097886 [TBL] [Abstract][Full Text] [Related]
12. [Cannabinoids as analgesics?]. Keup W Med Monatsschr Pharm; 1998 Sep; 21(9):275-83. PubMed ID: 9770990 [No Abstract] [Full Text] [Related]
13. [Cannabis: Use and misuse]. Tunving K Lakartidningen; 1976 Nov; 73(45):3867-72. PubMed ID: 979453 [No Abstract] [Full Text] [Related]
14. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Burns TL; Ineck JR Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552 [TBL] [Abstract][Full Text] [Related]
15. Cannabis, cannabinoids and schizophrenia: integration of the evidence. Cohen M; Solowij N; Carr V Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid system and neuroinflammation: implications for multiple sclerosis. Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512 [TBL] [Abstract][Full Text] [Related]
17. Brain cannabinoid systems as targets for the therapy of neurological disorders. Consroe P Neurobiol Dis; 1998 Dec; 5(6 Pt B):534-51. PubMed ID: 9974182 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in pain and inflammation. Mbvundula EC; Rainsford KD; Bunning RA Inflammopharmacology; 2004; 12(2):99-114. PubMed ID: 15265314 [TBL] [Abstract][Full Text] [Related]
19. Adolescence and drug abuse: biomedical consequences. Cohen S NIDA Res Monogr; 1980; 38():104-12. PubMed ID: 6121291 [No Abstract] [Full Text] [Related]
20. Cannabinoids for the treatment of neuropathic pain: clinical evidence. Ashton JC; Milligan ED Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]